Abiopharma

🔍 Taylor Andrew Lawrence (Executive)

Company: Orchestra BioMed Holdings, Inc. (OBIO)

Report Date: 2025-12-10

Detailed Transactions and Holdings:

• Sold 8,670 shares of Common Stock, par value $0.0001 per share at $4.67 per share (Direct)
  Date: 2025-12-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 454,945.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: Represents the withholding of shares by the Issuer to satisfy tax withholding obligations in connection with vesting of restricted stock units. No shares were sold in the market as a result of the vesting of these restricted stock units and the satisfaction of tax withholding obligations.